SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Crane Co/DE – ‘10-K’ for 12/31/19 – ‘EX-4.1’

On:  Monday, 2/24/20, at 5:59pm ET   ·   As of:  2/25/20   ·   For:  12/31/19   ·   Accession #:  1628280-20-2133   ·   File #:  1-01657

Previous ‘10-K’:  ‘10-K’ on 2/26/19 for 12/31/18   ·   Next:  ‘10-K’ on 2/23/21 for 12/31/20   ·   Latest:  ‘10-K’ on 2/22/24 for 12/31/23   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/25/20  Crane Co/DE                       10-K       12/31/19  123:20M                                    Workiva Inc Wde… FA01/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.52M 
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     48K 
 3: EX-21       Subsidiaries List                                   HTML     90K 
 4: EX-23.1     Consent of Experts or Counsel                       HTML     36K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     42K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     42K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     37K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     37K 
104: R1          Cover Page                                          HTML     96K  
54: R2          Consolidated Statements of Operations               HTML    111K 
19: R3          Consolidated Statements of Comprehensive Income     HTML     64K 
86: R4          Consolidated Balance Sheets                         HTML    143K 
103: R5          Consolidated Balance Sheets (Parenthetical)         HTML     52K  
53: R6          Consolidated Statements of Cash Flows               HTML    166K 
16: R7          Consolidated Statements of Changes in Equity        HTML     84K 
90: R8          Consolidated Statements of Changes in Equity        HTML     43K 
                (Parenthetical)                                                  
100: R9          Nature of Operations and Significant Accounting     HTML    249K  
                Policies                                                         
67: R10         Acquisitions And Divestitures                       HTML    107K 
115: R11         Segment Information                                 HTML    215K  
40: R12         Revenue                                             HTML    107K 
28: R13         Research And Development                            HTML     38K 
66: R14         Pension And Postretirement Benefits                 HTML    485K 
114: R15         Leases                                              HTML     72K  
39: R16         Stock-Based Compensation Plans                      HTML     91K 
27: R17         Income Taxes                                        HTML    212K 
68: R18         Accrued Liabilities                                 HTML     57K 
112: R19         Other Liabilities                                   HTML     45K  
63: R20         Commitments And Contingencies                       HTML    133K 
25: R21         Financing                                           HTML     85K 
92: R22         Fair Value Measurements                             HTML     44K 
108: R23         Restructuring Charges                               HTML    174K  
62: R24         Quarterly Results (Unaudited)                       HTML    105K 
24: R25         Subsequent Events                                   HTML     39K 
91: R26         Nature of Operations and Significant Accounting     HTML    269K 
                Policies (Policies)                                              
107: R27         Nature of Operations and Significant Accounting     HTML    252K  
                Policies (Tables)                                                
61: R28         Segment Information (Tables)                        HTML    213K 
26: R29         Revenue (Tables)                                    HTML    104K 
30: R30         Pension And Postretirement Benefits (Tables)        HTML    484K 
41: R31         Leases (Tables)                                     HTML     77K 
110: R32         Stock-Based Compensation Plans (Tables)             HTML     85K  
64: R33         Income Taxes (Tables)                               HTML    212K 
31: R34         Accrued Liabilities (Tables)                        HTML     60K 
42: R35         Other Liabilities (Tables)                          HTML     45K 
111: R36         Commitments And Contingencies (Tables)              HTML     82K  
65: R37         Financing (Tables)                                  HTML     65K 
29: R38         Restructuring Charges (Tables)                      HTML    158K 
43: R39         Quarterly Results (Unaudited) (Tables)              HTML    106K 
17: R40         Nature of Operations and Significant Accounting     HTML    103K 
                Policies (Narrative) (Details)                                   
52: R41         Nature of Operations and Significant Accounting     HTML     75K 
                Policies (Computation Of Basic And Diluted                       
                Earnings Per Share) (Details)                                    
102: R42         Nature of Operations and Significant Accounting     HTML     51K  
                Policies (Summary Of Inventories) (Details)                      
87: R43         Nature of Operations and Significant Accounting     HTML     70K 
                Policies (Summary Of Property, Plant And                         
                Equipment, Net) (Details)                                        
18: R44         Nature of Operations and Significant Accounting     HTML     62K 
                Policies (Schedule Of Changes To Goodwill)                       
                (Details)                                                        
55: R45         Nature of Operations and Significant Accounting     HTML     64K 
                Policies (Schedule Of Changes To Intangible                      
                Assets) (Details)                                                
105: R46         Nature of Operations and Significant Accounting     HTML     56K  
                Policies (Summary Of Intangible Assets) (Details)                
88: R47         Nature of Operations and Significant Accounting     HTML    111K 
                Policies (Accumulated Other Comprehensive Income                 
                (Loss)) (Details)                                                
14: R48         Nature of Operations and Significant Accounting     HTML     51K 
                Policies (Goodwill) (Details)                                    
56: R49         Nature of Operations and Significant Accounting     HTML     65K 
                Policies (Recently Adopted Accounting                            
                Pronouncements) (Details)                                        
46: R50         Nature of Operations and Significant Accounting     HTML     37K 
                Policies (Revenue, Remaining Performance                         
                Obligation) (Details)                                            
33: R51         Acquisitions And Divestitures (Details)             HTML    222K 
78: R52         Segment Information (Schedule Of Financial          HTML    118K 
                Information By Reportable Segment) (Details)                     
123: R53         Segment Information (Schedule Of Consolidated       HTML     72K  
                Financial Statements By Industry Segments)                       
                (Details)                                                        
45: R54         Segment Information (Schedule Of Net Sales And      HTML     71K 
                Assets By Geographic Region) (Details)                           
32: R55         Segment Information (Sales By Major Product Group)  HTML     95K 
                (Details)                                                        
77: R56         Revenue - Disaggregation of Revenue (Details)       HTML     94K 
122: R57         Revenue - Remaining Performance Obligations         HTML     45K  
                (Details)                                                        
44: R58         Revenue - Contract Assets and Contract Liabilities  HTML     46K 
                (Details)                                                        
34: R59         Research And Development (Details)                  HTML     38K 
81: R60         Pension And Postretirement Benefits (Narrative)     HTML    119K 
                (Details)                                                        
98: R61         Pension And Postretirement Benefits (Summary Of     HTML    105K 
                Benefit Obligations, Fair Value Of Plan Assets And               
                Funded Status) (Details)                                         
59: R62         Pension And Postretirement Benefits (Schedule Of    HTML     56K 
                Amounts Recognized In Consolidated Balance Sheets)               
                (Details)                                                        
22: R63         Pension And Postretirement Benefits (Schedule Of    HTML     49K 
                Amounts Recognized In Accumulated Other                          
                Comprehensive (Income) Loss) (Details)                           
80: R64         Pension And Postretirement Benefits (Schedule Of    HTML     55K 
                Accumulated And Projected Benefit Obligations)                   
                (Details)                                                        
97: R65         Pension And Postretirement Benefits (Schedule Of    HTML     46K 
                Information For Pension Plans With An Accumulated                
                Benefit Obligation In Excess Of Plan Assets)                     
                (Details)                                                        
58: R66         Pension And Postretirement Benefits (Components Of  HTML     66K 
                Net Periodic Benefits Cost) (Details)                            
21: R67         Pension And Postretirement Benefits (Schedule Of    HTML     49K 
                Weighted Average Assumptions Used To Determine                   
                Benefit Obligation) (Details)                                    
83: R68         Pension And Postretirement Benefits (Schedule Of    HTML     51K 
                Weighted Average Assumptions Used To Determine Net               
                Periodic Benefit Cost) (Details)                                 
94: R69         Pension And Postretirement Benefits (Schedule Of    HTML     40K 
                Assumed Health Care Cost Trend) (Details)                        
117: R70         Pension And Postretirement Benefits (Schedule Of    HTML     45K  
                One-Percentage-Point Change In Assumed Health Care               
                Cost Trend Rates) (Details)                                      
74: R71         Pension And Postretirement Benefits (Schedule Of    HTML     49K 
                Pension Plan Target Allocations And                              
                Weighted-Average Asset Allocations By Asset                      
                Category) (Details)                                              
36: R72         Pension And Postretirement Benefits (Schedule Of    HTML    104K 
                Fair Value Of Company Pension Plan Assets)                       
                (Details)                                                        
48: R73         Pension And Postretirement Benefits (Summary Of     HTML     56K 
                Estimated Future Benefit Payments) (Details)                     
118: R74         Leases - Narrative (Details)                        HTML     45K  
75: R75         Leases - Supplemental Balance Sheet Information     HTML     53K 
                (Details)                                                        
37: R76         Leases - Supplemental Cash Flow Information         HTML     45K 
                (Details)                                                        
49: R77         Leases - Future Minimum Lease Payment Obligations   HTML     55K 
                Under Operating Leases (Details)                                 
121: R78         Leases - Future Minimum Payments for Operating      HTML     56K  
                Leases Under ASC 840 (Details)                                   
72: R79         Stock-Based Compensation Plans (Narrative)          HTML    103K 
                (Details)                                                        
116: R80         Stock-Based Compensation Plans (Schedule Of         HTML     46K  
                Weighted-Average Assumptions For Grants Made)                    
                (Details)                                                        
73: R81         Stock-Based Compensation Plans (Schedule Of         HTML     69K 
                Company's Stock Option Plans) (Details)                          
35: R82         Stock-Based Compensation Plans (Schedule Of         HTML     72K 
                Changes Of Restricted Stock) (Details)                           
47: R83         Income Taxes (Schedule Of Income Before Taxes)      HTML     43K 
                (Details)                                                        
119: R84         Income Taxes (Schedule Of Provision For Income      HTML     66K  
                Taxes) (Details)                                                 
76: R85         Income Taxes (Reconciliation Of The Statutory U.S.  HTML     59K 
                Federal Rate To The Effective Tax Rate) (Details)                
38: R86         Income Taxes (Schedule Of Deferred Tax Assets And   HTML     80K 
                Liabilities) (Details)                                           
50: R87         Income Taxes (Summary Of Tax Loss And Tax Credit    HTML     72K 
                Carryforwards) (Details)                                         
120: R88         Income Taxes (Schedule Of Gross Unrecognized Tax    HTML     52K  
                Benefits Reconciliation) (Details)                               
71: R89         Income Taxes (Narrative) (Details)                  HTML     62K 
82: R90         Accrued Liabilities (Schedule Of Accrued            HTML     53K 
                Liabilities) (Detail)                                            
99: R91         Accrued Liabilities (Summary Of Warranty            HTML     49K 
                Liabilities) (Detail)                                            
60: R92         Other Liabilities (Schedule Of Other Liabilities)   HTML     45K 
                (Details)                                                        
23: R93         Commitments And Contingencies (Leases) (Details)    HTML     59K 
79: R94         Commitments And Contingencies (Asbestos Liability   HTML    174K 
                Narrative) (Details)                                             
96: R95         Commitments And Contingencies (Asbestos Claims      HTML    159K 
                Activity) (Details)                                              
57: R96         Commitments And Contingencies (Schedule Of Gross    HTML     59K 
                Settlement And Defense Costs) (Details)                          
20: R97         Commitments And Contingencies Other Contingencies   HTML     56K 
                (Details)                                                        
84: R98         Financing (Components Of Debt) (Details)            HTML    131K 
95: R99         Financing (Narrative) (Details)                     HTML    204K 
85: R100        Financing (Capitalization Of Long-Term Debt)        HTML     50K 
                (Details)                                                        
101: R101        Fair Value Measurements (Details)                   HTML     48K  
51: R102        Restructuring Charges (Narrative) (Details)         HTML    126K 
15: R103        Restructuring Charges (Summary of Restructuring     HTML    140K 
                Charges) (Details)                                               
89: R104        Quarterly Results (Unaudited) (Details)             HTML     85K 
106: R105        Subsequent Events (Details)                         HTML     48K  
69: XML         IDEA XML File -- Filing Summary                      XML    241K 
70: XML         XBRL Instance -- cr-20191231x10kq4_htm               XML   5.90M 
113: EXCEL       IDEA Workbook of Financial Reports                  XLSX    172K  
10: EX-101.CAL  XBRL Calculations -- cr-20191231_cal                 XML    363K 
11: EX-101.DEF  XBRL Definitions -- cr-20191231_def                  XML   1.28M 
12: EX-101.LAB  XBRL Labels -- cr-20191231_lab                       XML   2.88M 
13: EX-101.PRE  XBRL Presentations -- cr-20191231_pre                XML   1.91M 
 9: EX-101.SCH  XBRL Schema -- cr-20191231                           XSD    300K 
93: JSON        XBRL Instance as JSON Data -- MetaLinks              580±   895K 
109: ZIP         XBRL Zipped Folder -- 0001628280-20-002133-xbrl      Zip    584K  


‘EX-4.1’   —   Instrument Defining the Rights of Security Holders


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  
Exhibit 4.1


DESCRIPTION OF THE REGISTRANT’S SECURITIES
REGISTERED PURSUANT TO SECTION 12 OF THE
SECURITIES EXCHANGE ACT OF 1934
The following description sets forth certain material terms and provisions of the securities of Crane Co. (the “Company”) that are registered under Section 12 of the Securities Exchange Act of 1934, as amended. This description also summarizes certain relevant provisions of Delaware law. The following summary does not purport to be complete and is subject to, and is qualified in its entirety by reference to, the applicable provisions of Delaware law, the Company’s Amended and Restated Certificate of Incorporation (the Certificate of Incorporation) and the Company’s By-laws, as amended (the By-laws), copies of which are incorporated by reference as exhibits to the Annual Report on Form 10-K of which this exhibit is a part. The Company encourages you to read the Certificate of Incorporation, the By-laws and the applicable provisions of Delaware law for additional information.
The Certificate of Incorporation authorizes the issuance of 205,000,000 shares of capital stock, of which 200,000,000 shares are designated as common stock, par value $1.00 (“Common Stock”), and 5,000,000 shares are designated as preferred stock, par value $.01 (“Preferred Stock”). As of January 31, 2020, 59,149,706 shares of Common Stock were issued and outstanding, and no shares of Preferred Stock were issued and outstanding.
Common Stock
Holders of Common Stock are entitled to cast one vote per share on all matters on which the Company’s stockholders are entitled to vote. The number of votes required to take action by Crane’s stockholders are as provided in the Delaware General Corporation Law (the “DGCL”), the Certificate of Incorporation or the By-laws. Holders of Common Stock do not have cumulative voting rights or preemptive, redemption, subscription or conversion rights. Holders of Common Stock are entitled to receive dividends when and as declared by the Company’s Board of Directors out of funds legally available for the payment thereof. Subject to any preferential rights that may be granted to holders of Preferred Stock, holders of Common Stock are entitled to share ratably in all assets of the Company that are legally available for distribution to its stockholders in the event of its liquidation or dissolution.
The Company’s Board of Directors is authorized, subject to any limitations prescribed by law, without further stockholder approval, to provide for the issuance of shares of Preferred Stock in one or more series. Each series of Preferred Stock will have such rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences, as will be determined by the Company’s Board of Directors. It is not possible to state the actual effect of the issuance of any shares of Preferred Stock upon the rights of holders of the Common Stock until the Company’s Board of Directors determines the specific rights of the holders of such Preferred Stock. However, the effects might include, among other things:
impairing the dividend rights of the Common Stock;

diluting the voting power of the Common Stock;

impairing the liquidation rights of the Common Stock; and

delaying, deferring or preventing a change in control.
Certain Corporate Anti-Takeover Provisions
The Certificate of Incorporation and the By-laws contain a number of provisions relating to corporate governance and to the rights of shareholders. Certain of these provisions may be deemed to have a potential “anti-takeover” effect by delaying, deferring or preventing a change of control of the Company. These provisions include the following:
Preferred Stock. Our board of directors has the authority to issue one or more series of Preferred Stock with voting rights and other powers as the Company’s Board of Directors may determine, as described above.

1

Exhibit 4.1


Removal of Directors, Vacancies. Our stockholders are able to remove directors only by the affirmative vote of a majority of the voting power of the shares then entitled to vote at an election of directors. Vacancies on the Company’s Board of Directors may be filled only by the Company’s Board of Directors.
No Cumulative Voting. The Company’s stockholders do not have the right to cumulative votes in the election of directors.
No Stockholder Action by Written Consent; Calling of Special Meetings of Stockholders. The Certificate of Incorporation and the By-laws do not permit stockholder action without a meeting by any consent in writing. The Certificate of Incorporation and the By-laws also provide that special meetings of the Company’s stockholders may be called only by the Company’s Board of Directors or the Chairman of the Company’s Board of Directors.
Advance Notice Requirements for Stockholder Proposals and Director Nominations. The By-laws provide that stockholders seeking to nominate candidates for election as directors or to bring business before an annual meeting of stockholders must provide timely notice of their proposal in writing to the Company.
Delaware Law
The Company is subject to Section 203 of the DGCL. Subject to certain exceptions, Section 203 prevents a publicly held Delaware corporation from engaging in a “business combination” with any “interested stockholder” for three years following the date that the person became an interested stockholder, unless either the interested stockholder attained such status with the approval of our board of directors, the business combination is approved by our board of directors and stockholders in a prescribed manner or the interested stockholder acquired at least 85% of our outstanding voting stock in the transaction in which it became an interested stockholder. A “business combination” includes, among other things, a merger or consolidation involving us and the “interested stockholder” and the sale of more than 10% of our assets. In general, an “interested stockholder” is any entity or person beneficially owning 15% or more of our outstanding voting stock and any entity or person affiliated with or controlling or controlled by such entity or person. This provision may discourage or prevent unsolicited tender offers for our outstanding common stock.
Effects of Authorized but Unissued Stock
Authorized but unissued shares of Common Stock and Preferred Stock are available for future issuance without stockholder approval, subject to any limitations imposed by the listing standards of the New York Stock Exchange. These additional shares may be used for a variety of corporate finance transactions, acquisitions and employee benefit plans. The existence of authorized but unissued and unreserved Common Stock and Preferred Stock could make more difficult or discourage an attempt to obtain control of the Company by means of a proxy contest, tender offer, merger or otherwise. In addition, if the Company issues Preferred Stock, the issuance could adversely affect the voting power of holders of Common Stock and the likelihood that such holders will receive dividend payments and payments upon liquidation.
Transfer Agent and Registrar
The transfer agent and registrar for the Common Stock is Computershare Trust Company, N.A.
New York Stock Exchange Listing
Our common stock is listed on the New York Stock Exchange under the symbol “CR.”


2

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed as of:2/25/208-K
Filed on:2/24/208-K
1/31/204
For Period end:12/31/1911-K,  SD
 List all Filings 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/22/24  Crane NXT, Co.                    10-K       12/31/23  118:13M                                    Workiva Inc Wde… FA01/FA
 3/01/23  Crane NXT, Co.                    10-K       12/31/22  121:17M                                    Workiva Inc Wde… FA01/FA
 2/28/22  Crane NXT, Co.                    10-K       12/31/21  128:18M                                    Workiva Inc Wde… FA01/FA
 2/23/21  Crane NXT, Co.                    10-K       12/31/20  118:18M                                    Workiva Inc Wde… FA01/FA
Top
Filing Submission 0001628280-20-002133   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 8:28:05.1am ET